Redmile Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $988K | Sell |
|
|||||
|
2022
Q4 | $731K | Sell |
|
|||||
|
2022
Q3 | $1.97M | Hold |
|
|||||
|
2022
Q2 | $3.17M | Hold |
|
|||||
|
2022
Q1 | $3.02M | Sell |
|
|||||
|
2021
Q4 | $6.27M | Sell |
|
|||||
|
2021
Q3 | $32.5M | Buy |
|
|||||
|
2021
Q2 | $53.1M | Sell |
|
|||||
|
2021
Q1 | $79.7M | Buy |
|
|||||
|
2020
Q4 | $87.6M | Buy |
|
|||||
|
2020
Q3 | $56.8M | Buy |
|
|||||
|
2020
Q2 | $27.1M | Sell |
|
|||||
|
2020
Q1 | $13.7M | Sell |
|
|||||
|
2019
Q4 | $25.7M | Buy |
|
|||||
|
2019
Q3 | $26.9M | Sell |
|
|||||
|
2019
Q2 | $25.7M | Sell |
|
|||||
|
2019
Q1 | $28.7M | Buy |
|